Page results
-
A new surgical technique could remove the risk of urinary incontinence after surgery to remove the prostate for men with prostate cancer.
-
The UCLH@Home service is helping patients like 80-year-old Margaret Stone to continue their recovery in their own home under the care of their hospital team.
-
The Secretary of State for Health and Social Care, The Rt. Hon. Sajid Javid MP visited the National Hospital for Neurology and Neurosurgery (NHNN), earlier this week (Wednesday 4 May 2022).
-
Art and creativity can be a real tonic for health, says UCLH arts curator Guy Noble.
-
Well done to everyone who ran to support UCLH in the iconic London Landmarks Half Marathon on 2 April!
-
Researchers at UCLH and UCL have completed the first and only randomised trial to explore a new approach to treating aggressive lung cancer.
-
This page is for cancer patients receiving immunotherapy treatment.
-
This information is for patients receiving steroids for immunotherapy toxicity.
-
UCLH has recruited the first patient to a global study of a new drug in early development, called NI0752, which is thought to reduce the production of a protein in the brain called tau.
-
Preterm infants do not get used to repeated pain in the way that full-term infants, children and adults do habituate to pain, finds a study at UCLH and UCL.
File results
-
FOI/2024/0581 - Weight management services/ bariatric surgery/ access to Wegovy
-
FOI/2024/0582 - SACT (systemic anti-cancer therapy) treatments for endometrial cancer
-
FOI/2024/0583 - National inpatient survey improvements/ night-time noise levels/ ward lighting/ mealtime support
-
FOI/2024/0584 - Immunology Hidradenitis Suppurativa (HS) treatments
-
FOI/2024/0586 - Subject Access Requests (SAR) and Freedom of Information (FOI) requests for 2023/24
-
FOI/2024/0587 - Colorectal cancer treatments
-
FOI/2024/0589 - SACT Cancer report/ Drug Patient Level Contract Monitoring (DrPLCM) report
-
FOI/2024/0594 - Implementation of Federated Data Platform (FDP) and procurement of data platforms
-
FOI/2024/0595 - Capital estate activity for 2020-2024
-
FOI/2024/0597 - Urothelial cancer treatments